Literature DB >> 12841579

Isolation and characterization of a human putative receptor protein kinase cDNA STYK1.

Xin Ye1, Chaoneng Ji, Qingshan Huang, Chao Cheng, Rong Tang, Jian Xu, Li Zeng, Jianfeng Dai, Qihan Wu, Shaohua Gu, Yi Xie, Yumin Mao.   

Abstract

Protein kinases (PKs) represent a well studied but most diverse protein superfamily. The covalent, reversible linkage of phosphate to serine, threonine, and tyrosine residues of substrate proteins by protein kinases is probably ubiquitous cellular mechanism for regulation of physiological processes. It is known to us that most signaling pathways impinge at some point on protein kinases. Here we report a human putative receptor protein kinase cDNA STYK1. The STYK1 cDNA is 2749 base pairs in length and contains an open reading frame encoding 422 amino acids. The STYK1 gene is mapped to human chromosome 12p13 and 11 exons were found. RT-PCR showed that STYK1 is widely expressed in human tissues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12841579     DOI: 10.1023/a:1023934017174

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  18 in total

Review 1.  Structural analysis of receptor tyrosine kinases.

Authors:  S R Hubbard
Journal:  Prog Biophys Mol Biol       Date:  1999       Impact factor: 3.667

Review 2.  Transforming growth factor beta signaling mediators and modulators.

Authors:  C M Zimmerman; R W Padgett
Journal:  Gene       Date:  2000-05-16       Impact factor: 3.688

Review 3.  The serine, threonine, and/or tyrosine-specific protein kinases and protein phosphatases of prokaryotic organisms: a family portrait.

Authors:  L Shi; M Potts; P J Kennelly
Journal:  FEMS Microbiol Rev       Date:  1998-10       Impact factor: 16.408

4.  Molecular cloning and characterization of a novel protein serine/threonine kinase highly expressed in mouse embryo.

Authors:  K Kurioka; K Nakagawa; K Denda; K Miyazawa; N Kitamura
Journal:  Biochim Biophys Acta       Date:  1998-12-22

Review 5.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

Review 6.  How do protein kinases discriminate between serine/threonine and tyrosine? Structural insights from the insulin receptor protein-tyrosine kinase.

Authors:  S S Taylor; E Radzio-Andzelm; T Hunter
Journal:  FASEB J       Date:  1995-10       Impact factor: 5.191

Review 7.  Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling.

Authors:  T Hunter
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

Review 8.  Protein tyrosine kinase structure and function.

Authors:  S R Hubbard; J H Till
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

Review 9.  The complete code for a eukaryotic cell. Genome sequencing.

Authors:  M Johnston
Journal:  Curr Biol       Date:  1996-05-01       Impact factor: 10.834

10.  GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.

Authors:  R Wieser; J L Wrana; J Massagué
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

View more
  8 in total

1.  A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment.

Authors:  K Sean Kimbro; Kaitlin Duschene; Margeret Willard; Jodi-Ann Moore; Shalonda Freeman
Journal:  Mol Biol Rep       Date:  2007-04-06       Impact factor: 2.316

2.  Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer.

Authors:  Liang Hu; Hai-Yang Chen; Jian Cai; Yu Zhang; Chen-Ye Qi; Hui Gong; Yan-Xia Zhai; Hao Fu; Guang-Zhen Yang; Chun-Fang Gao
Journal:  BMC Cancer       Date:  2015-04-10       Impact factor: 4.430

3.  Identification of six polymorphisms as novel susceptibility loci for ischemic or hemorrhagic stroke by exome-wide association studies.

Authors:  Yoshiji Yamada; Jun Sakuma; Ichiro Takeuchi; Yoshiki Yasukochi; Kimihiko Kato; Mitsutoshi Oguri; Tetsuo Fujimaki; Hideki Horibe; Masaaki Muramatsu; Motoji Sawabe; Yoshinori Fujiwara; Yu Taniguchi; Shuichi Obuchi; Hisashi Kawai; Shoji Shinkai; Seijiro Mori; Tomio Arai; Masashi Tanaka
Journal:  Int J Mol Med       Date:  2017-05-03       Impact factor: 4.101

4.  Knockdown of Serine Threonine Tyrosine Kinase 1 (STYK1) Inhibits the Migration and Tumorigenesis in Glioma Cells.

Authors:  Jianping Zhou; Fan Wang; Bingli Liu; Lin Yang; Xueying Wang; Yu Liu
Journal:  Oncol Res       Date:  2016-10-27       Impact factor: 5.574

5.  Downregulation of GLUT3 impairs STYK1/NOK-mediated metabolic reprogramming and proliferation in NIH-3T3 cells.

Authors:  Weiye Shi; Yu Fu; Yingze Wang
Journal:  Oncol Lett       Date:  2021-05-14       Impact factor: 2.967

6.  Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer.

Authors:  Peng Chen; Wei-Miao Li; Qiang Lu; Jian Wang; Xiao-Long Yan; Zhi-Pei Zhang; Xiao-Fei Li
Journal:  BMC Cancer       Date:  2014-06-04       Impact factor: 4.430

7.  STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.

Authors:  Zhaowen Wang; Lei Qu; Biao Deng; Xing Sun; Shaohan Wu; Jianhua Liao; Junwei Fan; Zhihai Peng
Journal:  Sci Rep       Date:  2016-09-15       Impact factor: 4.379

8.  Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients.

Authors:  Luguang Chen; Chao Ma; Yun Bian; Chengwei Shao; Tiegong Wang; Jing Li; Xiaodan Chong; Li Su; Jianping Lu
Journal:  Oncotarget       Date:  2017-11-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.